NGC Update Service: November 21, 2011

-----Original Message-----
From: Agency for Healthcare Research and Quality (AHRQ)
Sent: 11/21/2011 5:01:54 PM
To: guyperea@live.com
Subject: NGC Update Service: November 21, 2011

November 21, 2011 New This Week Guideline Summaries American Gastroenterological Association Institute AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. American Society of Clinical Oncology (1) American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV nonâ€"small-cell lung cancer. (2) 2011 focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV nonâ€"small-cell lung cancer. This is an addendum to a previously published guideline summary. American Society of Plastic Surgeons Evidence-based clinical practice guideline: reduction mammaplasty. Royal College of Obstetricians and Gynaecologists Female genital mutilation and its management. Management of acute pelvic inflammatory disease. Management of monochorionic twin pregnancy. Preventing entry-related gynaecological laparoscopic injuries. Prevention and management of postpartum haemorrhage. Umbilical cord prolapse. U.S. Preventive Services Task Force Ocular prophylaxis for gonococcal ophthalmia neonatorum: U.S. Preventive Services Task Force reaffirmation recommendation statement. This updates a previously published guideline summary. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement. This updates a previously published guideline summary. Announcements Newly Submitted DHHS has updated their guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Health Awareness Topics - November 2011 American Diabetes Month (see related guidelines and the guideline synthesis page for various diabetes-related topics) COPD Awareness Month (see related guidelines and the guideline synthesis page for various COPD-related topics) Lung Cancer Awareness Month (see related guidelines) Pancreatic Cancer Awareness Month (see related guidelines) NGC Spotlight New research review added! Visit the AHRQ Evidence Reports page for a listing of reports produced under AHRQ's Evidence-based Practice Program and Effective Health Care Program. Conference News The Guidelines International Network (G-I-N) Conference 2012, will be held August 22-25, 2012 in Berlin, Germany. Submit abstracts until February 10, 2012. U.S. Food and Drug Administration (FDA) Advisories November 9, 2011: Trilipix (fenofibric acid): FDA notified healthcare professionals the cholesterol-lowering medicine Trilipix (fenofibric acid) may not lower a patient's risk of having a heart attack or stroke. FDA reviewed the data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Lipid trial, which found no significant difference in the risk of experiencing a major adverse cardiac event between the group treated with fenofibrate plus simvastatin compared with simvastatin alone. Information from the trial has been added to the Important Limitations of Use and Warnings and Precautions sections of the Trilipix physician label and to the patient Medication Guide. November 4, 2011: Tumor Necrosis Factor (TNF) blockers, Azathioprine and/or Mercaptopurine: Healthcare professionals should remain vigilant for cases of malignancy in patients treated with TNF blockers, and report such cases to MedWatch. FDA continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma or HSTCL, primarily in adolescents and young adults being treated for Crohn's disease and ulcerative colitis with TNF blockers, as well as with azathioprine, and/or mercaptopurine. NGC's Sister Resources Find Innovations and QualityTools classified by disease or clinical category, patient population, setting of care, stage of care, and more in AHRQ's Health Care Innovations Exchange Web site. Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC). Update your subscriptions, modify your password or E-mail address, or stop subscriptions at any time on your Subscriber Preferences Page If you have any questions or problems with the subscription service, E-mail: updates@subscriptions.ahrq.gov. For other inquiries, Contact Us. If you have questions about AHRQ's activities, please try to find the answers by checking our Home Page, where we have established links to various topical areas. Also check the News & Information section and Frequently Asked Questions. You may also Search or Browse the Web Site. These features are designed to assist you in obtaining the information you are seeking. This service is provided to you at no charge by the Agency for Healthcare Research and Quality (AHRQ). This email was sent to guyperea@live.com using GovDelivery, on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 540 Gaither Road · Rockville, MD 20850 · 301-427-1364